91 related articles for article (PubMed ID: 19916732)
1. Modification of mammalian reoviruses for use as oncolytic agents.
Van Den Wollenberg DJ; Van Den Hengel SK; Dautzenberg IJ; Kranenburg O; Hoeben RC
Expert Opin Biol Ther; 2009 Dec; 9(12):1509-20. PubMed ID: 19916732
[TBL] [Abstract][Full Text] [Related]
2. Noncanonical Cell Death Induction by Reassortant Reovirus.
Rodríguez Stewart RM; Raghuram V; Berry JTL; Joshi GN; Mainou BA
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847857
[TBL] [Abstract][Full Text] [Related]
3. Exploring Reovirus Plasticity for Improving Its Use as Oncolytic Virus.
Kemp V; Hoeben RC; van den Wollenberg DJ
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712782
[TBL] [Abstract][Full Text] [Related]
4. Delivery of Oncolytic Reovirus by Cell Carriers.
Ilett EJ
Methods Mol Biol; 2020; 2058():229-236. PubMed ID: 31486041
[TBL] [Abstract][Full Text] [Related]
5. Gene-specific inhibition of reovirus replication by RNA interference.
Kobayashi T; Chappell JD; Danthi P; Dermody TS
J Virol; 2006 Sep; 80(18):9053-63. PubMed ID: 16940517
[TBL] [Abstract][Full Text] [Related]
6. Comparative sequence analyses of a new mammalian reovirus genome and the mammalian reovirus S1 genes from six new serotype 2 human isolates.
Song L; Zhou Y; He J; Zhu H; Huang R; Mao P; Duan Q
Virus Genes; 2008 Dec; 37(3):392-9. PubMed ID: 18810628
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic reovirus synergizes with chemotherapeutic agents to promote cell death in canine mammary gland tumor.
Igase M; Hwang CC; Kambayashi S; Kubo M; Coffey M; Miyama TS; Baba K; Okuda M; Noguchi S; Mizuno T
Can J Vet Res; 2016 Jan; 80(1):21-31. PubMed ID: 26733729
[TBL] [Abstract][Full Text] [Related]
8. Reovirus RNA recombination is sequence directed and generates internally deleted defective genome segments during passage.
Smith SC; Gribble J; Diller JR; Wiebe MA; Thoner TW; Denison MR; Ogden KM
J Virol; 2021 Mar; 95(8):. PubMed ID: 33472930
[TBL] [Abstract][Full Text] [Related]
9. A previously unknown reovirus of bat origin is associated with an acute respiratory disease in humans.
Chua KB; Crameri G; Hyatt A; Yu M; Tompang MR; Rosli J; McEachern J; Crameri S; Kumarasamy V; Eaton BT; Wang LF
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11424-9. PubMed ID: 17592121
[TBL] [Abstract][Full Text] [Related]
10. Deciphering molecular mechanisms stabilizing the reovirus-binding complex.
Dos Santos Natividade R; Koehler M; Gomes PSFC; Simpson JD; Smith SC; Gomes DEB; de Lhoneux J; Yang J; Ray A; Dermody TS; Bernardi RC; Ogden KM; Alsteens D
Proc Natl Acad Sci U S A; 2023 May; 120(21):e2220741120. PubMed ID: 37186838
[TBL] [Abstract][Full Text] [Related]
11. The hitchhiker's guide to virotherapy.
Donnelly O; Vile R; Pandha H; Harrington K; Melcher A
Oncotarget; 2012 Aug; 3(8):735-6. PubMed ID: 22964541
[No Abstract] [Full Text] [Related]
12. Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment.
Cristi F; Walters M; Narayan N; Agopsowicz K; Hitt MM; Shmulevitz M
Mol Ther Oncolytics; 2023 Dec; 31():100743. PubMed ID: 38033400
[TBL] [Abstract][Full Text] [Related]
13. Quantification of the host response proteome after mammalian reovirus T1L infection.
Berard AR; Cortens JP; Krokhin O; Wilkins JA; Severini A; Coombs KM
PLoS One; 2012; 7(12):e51939. PubMed ID: 23240068
[TBL] [Abstract][Full Text] [Related]
14. Evaluating a combination treatment of NK cells and reovirus against bladder cancer cells using an in vitro assay to simulate intravesical therapy.
Lim Y; Park J; Lim JE; Park M; Koh SK; Lee M; Kim SK; Lee SH; Song KH; Park DG; Kim HY; Jeong BC; Cho D
Sci Rep; 2024 Mar; 14(1):7390. PubMed ID: 38548803
[TBL] [Abstract][Full Text] [Related]
15. Cytocidal Effect of Irradiation on Gastric Cancer Cells Infected with a Recombinant Mammalian Orthoreovirus Expressing a Membrane-Targeted KillerRed.
Shirasaka Y; Yamada K; Etoh T; Noguchi K; Hasegawa T; Ogawa K; Kobayashi T; Nishizono A; Inomata M
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256912
[TBL] [Abstract][Full Text] [Related]
16. Creation and characterization of a recombinant mammalian orthoreovirus expressing σ1 fusion proteins encoding human epidermal growth factor receptor 2 peptides.
Jandick NA; Miller CL
Virology; 2023 Oct; 587():109871. PubMed ID: 37634292
[TBL] [Abstract][Full Text] [Related]
17. Window of opportunity studies: Do they fulfil our expectations?
Schmitz S; Duhoux F; Machiels JP
Cancer Treat Rev; 2016 Feb; 43():50-7. PubMed ID: 26827692
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Reoviral Cytolysis (II): Cellular Stemness.
Bourhill T; Rohani L; Kumar M; Bose P; Rancourt D; Johnston RN
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515162
[TBL] [Abstract][Full Text] [Related]
19. Reovirus: a targeted therapeutic--progress and potential.
Maitra R; Ghalib MH; Goel S
Mol Cancer Res; 2012 Dec; 10(12):1514-25. PubMed ID: 23038811
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
